Efficacy of Bone-marrow-derived and Placenta-derived Multipotent Mesenchymal Stem / Stromal Cells for Osteoarthritis
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
To define the clinical effects of intra-articular transplantation of bone-marrow-derived
(BM-MMSCs) and placenta-derived multipotent mesenchymal stem / stromal cells (P-MMSCs) for
knee osteoarthritis.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Institute of Cell Therapy
Collaborators:
Kyiv City Clinical Hospital № 6 The Institute of Traumatology and Orthopedics of NAMS of Ukraine